NSE filing, NSE: IGIL. Summary written from the filing by ALFA Finder's alert engine.
International Gemological Institute Ltd: key numbers
- Share price
- ₹398.45
- Market cap
- ₹17,219 Cr
- Revenue (annual)
- ₹1,598 Cr
- Net profit (annual)
- ₹711.2 Cr
- P/E (TTM)
- 25.9×Sector 43.1×
- Promoter holding
- 76.55%+0.00% QoQ
- FII holding
- 8.79%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from International Gemological Institute Ltd
All →International Gemological Institute Earnings Call Transcript: Key Takeaways
IGI delivered its best-ever quarter, significantly outperforming its prior guidance driven by explosive Lab-Grown Diamond (LGD) demand.
- Call
- Guides 27% growth
International Gemological Institute Results Update
International Gemological Institute Limited reported Q2 FY27 revenue growth of 31% YoY to INR 3,980 Mn and PAT growth of 43% YoY to INR 1,858 Mn.
International Gemological Institute Investor Presentation: Key Takeaways
IGI reported strong Q2FY27 performance with consolidated revenue growing 31% YoY to INR 3,980 Mn. PAT surged 43% YoY with margins expanding 400 bps to 46.7%.
International Gemological Institute Q2 FY27 Results: Net Profit ₹185.8 Cr, Up 43.1% YoY
International Gemological Institute Ltd reported revenue from operations of ₹398 Cr (+31.1% YoY) and net profit of ₹185.8 Cr (+43.1% YoY) for Q2 FY27.
- Key figure
- Net profit ₹185.8 Cr · +43.1% YoY
International Gemological Institute Other Announcement
International Gemological Institute Limited reported an unsolicited ESG score of 63 from NSE Sustainability for FY 2025-26. The company did not engage the agency for this rating.
International Gemological Institute Board Meeting Date
IGIL intimated BSE/NSE that its Board meeting is scheduled for 21 Oct 2026 to approve Q2/H1 FY27 results. The trading window is closed from 1 Oct 2026 until 48 hours post-results.
Other employee stock options announcements
All →Aye Finance Employee Stock Options
Aye Finance's employee welfare trust transferred 89,501 equity shares to grantees on exercising ESOP options. The share capital remains unchanged, so no new issuance occurs.
Aarti Pharmalabs Employee Stock Options
Aarti Pharmalabs granted 850 stock options to employees under its PSOP 2023 at Rs.5 exercise price. This is an employee incentive grant, not a capital raise.
OnEMI Technology Solutions Employee Stock Options
OnEMI Technology allotted 69,000 equity shares on exercise of employee stock options under the Kissht ESOP 2022 plan. The shares rank pari passu with existing equity.
Bliss GVS Pharma Employee Stock Options
Bliss GVS Pharma seeks shareholder approval via postal ballot for new employee stock option plans 2026. Up to 26,50,000 options are proposed; voting closes November 27, 2026.
Bandhan Bank Employee Stock Options
Bandhan Bank's board granted 32,98,871 stock options under ESOP Series 1 (Tranche 9) at Rs 151.91 per option. The options vest over four years, with each option convertible into one equity share.
Maxvolt Energy Industries Employee Stock Options
Maxvolt Energy granted 5,01,726 ESOPs to six employees under its MEIL ESOP 2025 scheme at exercise prices of ₹30 and ₹45. Options vest over four years, with exercise windows following vesting.
- Execution
- Vesting over 4 years from grant (25% at 2nd, 25% at 3rd, 50% at 4th anniversary); exercise over 3 years from each vesting date